Psychedelic Medicine Syndicate (PsyMS or PsyMed Ventures) is an investment syndicate on Angel List that invests in early-stage psychedelics companies.
Psychedelic Medicine Syndicate
From their website
“The timing is right, and the market opportunity is huge: initial markets are around $15-20B with the potential to reach markets totaling as much as $200B. The results will be positive for society as well as participants in the space.
Our syndicate will provide capital to founders building companies that align healing, sustainability, and profitability.”
Key Staff
- Dina Burkitbayeva
- Greg Kubin
- Matias Serebrinsky
Investments
- ATAI Life Sciences
- Bexson Biomedical
- Bright Minds Biosciences
- Maya Health
- Terran Biosciences
- Journey Clinical
- Tactogen
- Delix Therapeutics
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates